These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33332384)

  • 1. Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes.
    Byrjalsen A; Hansen TVO; Stoltze UK; Mehrjouy MM; Barnkob NM; Hjalgrim LL; Mathiasen R; Lautrup CK; Gregersen PA; Hasle H; Wehner PS; Tuckuviene R; Sackett PW; Laspiur AO; Rossing M; Marvig RL; Tommerup N; Olsen TE; Scheie D; Gupta R; Gerdes AM; Schmiegelow K; Wadt K
    PLoS Genet; 2020 Dec; 16(12):e1009231. PubMed ID: 33332384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.
    Goudie C; Witkowski L; Cullinan N; Reichman L; Schiller I; Tachdjian M; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Clark ME; Clinton C; Coltin H; Felton K; Fernandez CV; Fleming AJ; Fuentes-Bolanos N; Gibson P; Grant R; Hammad R; Harrison LW; Irwin MS; Johnston DL; Kane S; Lafay-Cousin L; Lara-Corrales I; Larouche V; Mathews N; Meyn MS; Michaeli O; Perrier R; Pike M; Punnett A; Ramaswamy V; Say J; Somers G; Tabori U; Thibodeau ML; Toupin AK; Tucker KM; van Engelen K; Vairy S; Waespe N; Warby M; Wasserman JD; Whitlock JA; Sinnett D; Jabado N; Nathan PC; Shlien A; Kamihara J; Deyell RJ; Ziegler DS; Nichols KE; Dendukuri N; Malkin D; Villani A; Foulkes WD
    JAMA Oncol; 2021 Dec; 7(12):1806-1814. PubMed ID: 34617981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic predisposition in children with cancer - affected families' acceptance of Trio-WES.
    Brozou T; Taeubner J; Velleuer E; Dugas M; Wieczorek D; Borkhardt A; Kuhlen M
    Eur J Pediatr; 2018 Jan; 177(1):53-60. PubMed ID: 28929227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes.
    Hebert R; Cullinan N; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Coltin H; Deyell RJ; Felton K; Fernandez CV; Fleming AJ; Gibson P; Hammad R; Jabado N; Johnston DL; Lafay-Cousin L; Larouche V; Leblanc-Desrochers C; Michaeli O; Perrier R; Pike M; Say J; Schiller I; Toupin AK; Vairy S; van Engelen K; Waespe N; Villani A; Foulkes WD; Malkin D; Reichman L; Goudie C
    J Med Genet; 2023 Nov; 60(12):1218-1223. PubMed ID: 37460202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities for Improving Detection of Cancer Predisposition Syndromes in Pediatric Solid Tumor Patients.
    Hu B; Kirkey D; Wakeling A; McGuinness M; Kreimer S; Crane J; Spunt SL
    J Pediatr Hematol Oncol; 2024 Aug; 46(6):311-318. PubMed ID: 38884491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents-To Test or not to Test?
    Kratz CP; Lupo PJ; Zelley K; Schienda J; Nichols KE; Stewart DR; Malkin D; Brodeur GM; Maxwell K; Plon SE; Walsh MF
    Clin Cancer Res; 2024 May; 30(9):1733-1738. PubMed ID: 38411636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of a decision-support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumors.
    Goudie C; Cullinan N; Villani A; Mathews N; van Engelen K; Malkin D; Irwin MS; Foulkes WD
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27390. PubMed ID: 30117275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients.
    Schroeder C; Faust U; Krauße L; Liebmann A; Abele M; Demidov G; Schütz L; Kelemen O; Pohle A; Gauß S; Sturm M; Roggia C; Streiter M; Buchert R; Armenau-Ebinger S; Nann D; Beschorner R; Handgretinger R; Ebinger M; Lang P; Holzer U; Skokowa J; Ossowski S; Haack TB; Mau-Holzmann UA; Dufke A; Riess O; Brecht IB
    Eur J Hum Genet; 2023 Oct; 31(10):1139-1146. PubMed ID: 37507557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors.
    Hansford JR; Das A; McGee RB; Nakano Y; Brzezinski J; Scollon SR; Rednam SP; Schienda J; Michaeli O; Kim SY; Greer MC; Weksberg R; Stewart DR; Foulkes WD; Tabori U; Pajtler KW; Pfister SM; Brodeur GM; Kamihara J
    Clin Cancer Res; 2024 Jun; 30(11):2342-2350. PubMed ID: 38573059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline whole genome sequencing in adults with multiple primary tumors.
    Wang Y; Ding Q; Prokopec S; Farncombe KM; Bruce J; Casalino S; McCuaig J; Szybowska M; van Engelen K; Lerner-Ellis J; Pugh TJ; Kim RH
    Fam Cancer; 2023 Oct; 22(4):513-520. PubMed ID: 37481477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management.
    McGee RB; Oak N; Harrison L; Xu K; Nuccio R; Blake AK; Mostafavi R; Lewis S; Taylor LM; Kubal M; Ouma A; Hines-Dowell SJ; Cheng C; Furtado LV; Nichols KE
    Clin Cancer Res; 2023 Apr; 29(7):1243-1251. PubMed ID: 36693186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel.
    Byrjalsen A; Diets IJ; Bakhuizen J; Hansen TVO; Schmiegelow K; Gerdes AM; Stoltze U; Kuiper RP; Merks JHM; Wadt K; Jongmans M
    Fam Cancer; 2021 Oct; 20(4):279-287. PubMed ID: 34061292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
    Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel.
    Jiang W; Li L; Ke CF; Wang W; Xiao BY; Kong LH; Tang JH; Li Y; Wu XD; Hu Y; Guo WH; Wang SZ; Wan DS; Xu RH; Pan ZZ; Ding PR
    J Med Genet; 2022 Apr; 59(4):370-376. PubMed ID: 33563768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An eHealth decision-support tool to prioritize referral practices for genetic evaluation of patients with Wilms tumor.
    Cullinan N; Villani A; Mourad S; Somers GR; Reichman L; van Engelen K; Stephens D; Weksberg R; Foulkes WD; Malkin D; Grant R; Goudie C
    Int J Cancer; 2020 Feb; 146(4):1010-1017. PubMed ID: 31286500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
    Feliubadaló L; López-Fernández A; Pineda M; Díez O; Del Valle J; Gutiérrez-Enríquez S; Teulé A; González S; Stjepanovic N; Salinas M; Capellá G; Brunet J; Lázaro C; Balmaña J;
    Int J Cancer; 2019 Nov; 145(10):2682-2691. PubMed ID: 30927264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
    Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
    Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
    Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
    J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer.
    Wagener R; Taeubner J; Walter C; Yasin L; Alzoubi D; Bartenhagen C; Attarbaschi A; Classen CF; Kontny U; Hauer J; Fischer U; Dugas M; Kuhlen M; Borkhardt A; Brozou T
    Eur J Hum Genet; 2021 Aug; 29(8):1301-1311. PubMed ID: 33840814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.